Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07591558
EARLY_PHASE1

The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis

Sponsor: King Abdullah University Hospital

View on ClinicalTrials.gov

Summary

Atelectasis is considered a common complication in the perioperative period, especially following surgeries under general anesthesia. Postoperative atelectasis could occur anytime during the perioperative period from intraoperative period to 24 hours postoperative and contribute to a variety of other complications, including hypoxemia and pneumonia. In the literature, several methods were utilized to combat this phenomenon, therefore, we investigate the role of intraoperative salbutamol in reducing the incidence of atelectasis. It is well known that salbutamol could be an adjunctive bronchodilator medication used in the intraoperative anesthetic regimens.

Official title: The Role Intraoperative Salbutamol Inhaler Usage as Part of Intraoperative Regimen in Preventing Atelectasis Following Thoracic, Abdominal and Spinal Surgery in Diabetics Population

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-06

Completion Date

2026-12

Last Updated

2026-05-15

Healthy Volunteers

No

Interventions

DRUG

Salbutamol (Ventolin®)

-4 puffs of salbutamol (each puff = 100 µg, total dose 200-400 µg)

Locations (1)

King Abdullah University Hospital

Irbid, Jordan